Topic: ‘Proactive Post-Market Surveillance, 510(K) Update, and Real-World Evidence: Can It Improve Patient Safety, Outcomes and Provide a Competitive Edge?’
(PRWeb May 20, 2019)
Read the full story at https://www.prweb.com/releases/greenberg_traurigs_marcella_c_ducca_speaks_at_international_society_for_pharmacoeconomics_and_outcomes_research_2019_conference/prweb16323996.htm